In a small randomized trial, people who took capsules containing donated gut microbiomes experienced fewer gastrointestinal ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Computational research conducted by scientists from Washington University in St. Louis shows that GLP-1 agonists can have ...
A groundbreaking medication capable of preventing type 2 diabetes by up to 85% is offering new hope to those at risk, a ...
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...